Attached files

file filename
EX-99.1 - EX-99.1 - CANTEL MEDICAL LLCa15-2391_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  January 15, 2015

 

CANTEL MEDICAL CORP.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-31337

 

22-1760285

(State or other jurisdiction

 

(Commission

 

(IRS Identification

of incorporation)

 

File Number)

 

Number)

 

150 Clove Road, Little Falls, New Jersey

 

07424

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (973) 890-7220

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 7.01                   Regulation FD Disclosure

 

Attached hereto as Exhibit 99.1 is an investor presentation of Cantel Medical Corp. (the “Company”), which may be used in presentations by Company management to investors, analysts and others from time to time, including a presentation to be made on January 15, 2015.  The presentation will be posted on the Company’s website, www.cantelmedical.com. The information included in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended.

 

Item 9.01                   Financial Statements and Exhibits

 

(d) Exhibits

 

99.1 Cantel Medical Corp. Investor Presentation — January 2015

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CANTEL MEDICAL CORP.

 

 

 

 

 

By:

/s/ Eric W. Nodiff

 

 

Eric W. Nodiff

 

 

Executive Vice President and General Counsel

 

 

Dated: January 15, 2015

 

 

3



 

Exhibit Index

 

Exhibit No.

 

Exhibit Description

 

 

 

99.1

 

Cantel Medical Corp. Investor Presentation — January 2015

 

4